Leadership Overview
INCYTE has 8 executives leading key functions including strategy, operations, finance, human resources, information technology, research, and development.
Driven by innovation, INCYTE is dedicated to discovering, developing, and commercializing novel therapeutics to address unmet medical needs, impacting patient lives globally through its biopharmaceutical expertise.
Driven by innovation, INCYTE is dedicated to discovering, developing, and commercializing novel therapeutics to address unmet medical needs, impacting patient lives globally through its biopharmaceutical expertise.
Leadership Roles at INCYTE
William Meury - President & Chief Executive Officer
William Meury, the President & Chief Executive Officer at INCYTE, directs the overarching corporate strategy and operational execution. Meury guides the company's focus on discovering, developing, and commercializing novel therapeutics, ensuring alignment with market needs and patient outcomes. Overseeing all business units, the President & Chief Executive Officer drives the expansion of INCYTE's product portfolio, including key treatments for myelofibrosis, polycythemia vera, and chronic myeloid leukemia. This leadership role involves fostering innovation across the organization and ensuring the company's long-term growth trajectory. By championing strategic partnerships and market penetration, William Meury directly influences INCYTE's global impact in the biopharmaceutical sector.
Suketu Upadhyay - Chief Financial Officer & Executive VP
Suketu Upadhyay, the Chief Financial Officer & Executive VP at INCYTE, manages all financial operations and strategic fiscal planning. Upadhyay oversees budgeting, forecasting, investor relations, and capital allocation to support the company's research, development, and commercialization efforts. This critical position ensures the financial health and sustainability of INCYTE's biopharmaceutical endeavors, including the successful market introduction of treatments for various cancers. By driving financial discipline and strategic investment, the Chief Financial Officer & Executive VP enables the expansion of therapeutic pipelines. Suketu Upadhyay's financial acumen is essential for navigating the complex economic landscape of the pharmaceutical industry and maximizing shareholder value.
Suky Upadhyay - Executive Vice President & Chief Financial Officer
Suky Upadhyay, the Executive Vice President & Chief Financial Officer at INCYTE, spearheads financial strategy and resource management. Upadhyay is responsible for financial planning, reporting, and capital deployment to fuel INCYTE's biopharmaceutical innovation and market expansion. This role ensures robust financial controls and strategic investments in drug discovery and development programs, including treatments for hematologic malignancies and solid tumors. By optimizing financial performance and managing risk, the Executive Vice President & Chief Financial Officer supports the company's long-term growth and commitment to patient care. Suky Upadhyay's leadership ensures INCYTE maintains a strong financial foundation to achieve its therapeutic objectives.
Pablo Cagnoni - President, Global Head of Research & Development
Pablo Cagnoni, the President, Global Head of Research & Development at INCYTE, directs the company's comprehensive R&D strategy and execution. Cagnoni oversees the discovery and early-stage development of innovative therapeutics, focusing on areas of significant unmet medical need. This leadership role is pivotal in identifying and advancing promising drug candidates through the preclinical and clinical development phases, including novel approaches to oncology and inflammation. By fostering a culture of scientific excellence and collaboration, the President, Global Head of Research & Development ensures INCYTE remains at the forefront of biopharmaceutical innovation. Pablo Cagnoni's strategic vision guides the development of next-generation treatments for patients worldwide.
Jennifer Liu - Chief of Staff
Jennifer Liu, the Chief of Staff at INCYTE, facilitates strategic initiatives and operational efficiency across the executive team. Liu supports the President & Chief Executive Officer by managing key projects and ensuring seamless communication between departments. This role involves coordinating cross-functional efforts to advance the company's development and commercialization pipelines for critical therapeutics. By streamlining internal processes and driving project management, the Chief of Staff enhances the organization's ability to respond to market dynamics. Jennifer Liu's contributions are vital to maintaining focus on INCYTE's mission of delivering innovative treatments to patients.
Soni Basi - Executive Vice President & Chief Human Resources Officer
Soni Basi, the Executive Vice President & Chief Human Resources Officer at INCYTE, leads all human capital strategies and organizational development initiatives. Basi cultivates a high-performance culture that supports INCYTE's mission of discovering and developing innovative therapeutics. This role encompasses talent acquisition, employee engagement, compensation and benefits, and fostering a diverse and inclusive workplace environment. By aligning HR strategies with business objectives, the Executive Vice President & Chief Human Resources Officer ensures the organization has the skilled workforce necessary to advance its biopharmaceutical pipeline. Soni Basi's leadership is fundamental to attracting and retaining top talent critical for INCYTE's continued success.
Andrew Blyton - Vice President & Chief Information Officer
Andrew Blyton, the Vice President & Chief Information Officer at INCYTE, directs the company's technology strategy and digital infrastructure. Blyton oversees the implementation and management of IT systems that support INCYTE's research, development, and commercial operations, ensuring data security and operational efficiency. This position is crucial for enabling the seamless flow of information required for drug discovery and patient access to therapeutics. By driving technological innovation, the Vice President & Chief Information Officer enhances the company's ability to leverage data analytics and digital tools. Andrew Blyton's expertise ensures INCYTE maintains a robust and secure technological foundation to achieve its biopharmaceutical goals.
Steven Stein - Executive VP, Chief Medical Officer & Head of Late-stage Development
Steven Stein, the Executive VP, Chief Medical Officer & Head of Late-stage Development at INCYTE, leads the clinical strategy and execution for the company's therapeutic pipeline. Stein oversees the design and implementation of late-stage clinical trials, ensuring rigorous evaluation of drug efficacy and safety for regulatory approval. This critical function drives the advancement of novel treatments for various cancers and inflammatory diseases, directly impacting patient access to life-changing therapies. By guiding clinical development programs, the Executive VP, Chief Medical Officer & Head of Late-stage Development ensures INCYTE's pipeline meets stringent medical and regulatory standards. Steven Stein's medical leadership is paramount to translating scientific discovery into approved treatments.
Explore Leadership Teams in Manufacturing
Founded in 1891 and headquartered in Rahway, NJ, Merck & Co., Inc. is a global healthcare company delivering innovative solutions through prescription medicines, biologic therapies, vaccines, and animal health products.
Company Leadership NM
RS
GO
Zoetis discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, medicated feed additives that offer medicines to livestock; and other pharmaceutical products, which comprise allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. It markets to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company is headquartered in Parsippany, New Jersey.
Company Leadership GT
RV
LP
MT
Founded in 1973 and headquartered in Bangalore, India, Micro Lab is a pharmaceutical manufacturer, wholesaler, and R&D company.
Company Leadership MH
RK
RB
PM
Founded in 1990, Divi's Laboratories is a pharmaceutical company that specializes in the manufacturing in custom synthesizes generic APIs, intermediates and nutraceutical ingredients. Divi's Laboratories is located in India.
Company Leadership
KL
MJ
Frequently Asked Questions Regarding INCYTE Top Executives and Leadership Team
